Recent Quarter Total Invested
$469,203
Recent Quarter Institutional Ownership Percentage
0.3%
Total Invested of Last Quarter
$731,097
Ownership Percentage of Last Quarter
0.32%
Innate Pharma S.A. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
OPTIVER HOLDING B.V. | 08/14/2024 | 87,352 | $169,463 | 23.79% | 0.11% |
EXCHANGE TRADED CONCEPTS, LLC | 08/13/2024 | 86,237 | $167,300 | -23.73% | 0.11% |
MORGAN STANLEY | 10/17/2024 | 43,524 | $84,437 | -1.36% | 0.05% |
CITADEL ADVISORS LLC | 08/14/2024 | 23,527 | $45,642 | 100.00% | 0.03% |
BARCLAYS PLC | 08/14/2024 | 412 | $1,000 | 0.00% | 0.00% |
UBS GROUP AG | 08/14/2024 | 297 | $576 | 41.43% | 0.00% |
RHUMBLINE ADVISERS | 08/01/2024 | 205 | $397 | 0.00% | 0.00% |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/08/2024 | 200 | $388 | 0.00% | 0.00% |
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
JANE STREET GROUP, LLC | 08/15/2024 | 0 | $0 | -100.00% | 0.00% |
Innate Pharma S.A.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of IPHA shares?
During the previous two years, 9 institutional investors and hedge funds held shares of Innate Pharma S.A.. The most heavily invested institutionals were:
Optiver Holding B.V.: 86,788
EXCHANGE TRADED CONCEPTS, LLC: 77,350
MORGAN STANLEY: 43,524
CITADEL ADVISORS LLC: 21,267
UBS Group AG: 8,408
BARCLAYS PLC: 307
-
What percentage of Innate Pharma S.A. stock is owned by institutional investors?
0.30% of Innate Pharma S.A. stock is owned by institutional investors.
-
How much institutional buying is happening at IPHA ?
Institutional investors have bought a total of 238,064 shares in the last 24 months. This purchase volume represents approximately $388,044 in transactions.